Phosphatidylinositol polyphosphates (phosphoinositides, PIP[n]ns) are key signaling molecules in endo-and exocytosis, vesicular trafficking of proteins, transduction of extracellular signals, remodeling of the actin cytoskeleton, regulation of calcium flux, and apoptosis. A detailed understanding of the mechanisms by which phosphoinositides elicit their effects has been limited by the difficulty of getting PIP[n]s into cells; it has also been difficult to monitor changes in PIP[n] structure and localization when cell physiology is altered. To address this need, Echelon Research Laboratories (ERL) will first develop the Shuttle-PIP system, a simple and rapid method for delivery of PIP[n]s and their fluorescently-labeled analogs into living eukaryotic cells. Polyamine shuttle molecules would carry the polyanionic PIP[n] cargo into living animal, plant, and yeast cells. The process can be monitored using laser confocal or fluorescence microscopy by following the fluorescently-labeled, cell-permeable PIP[n]s, the fluorescent shuttle molecule, or both. Second, ERL will develop Shuttle-PIP kits for each of the eight PIP[n]s for delivery and subcellular visualization. Preliminary studies with NBD-PtdIns(4,5)P2 show that intracellular delivery is possible. Phase I will demonstrate feasibility for other PIP[n]s, optimize conditions for different cells, and optimize synthesis of the fluorescent shuttles and PIP[n]s.

Proposed Commercial Applications

Easy-to-use cell permeant preparations of fluorescently-labeled PIP[n]s would benefit basic and applied research. Changes of PIP[n]s in space and time can be monitored following extracellular stimulation, and agonist or antagonists for a given cellular process can be identified in cell-based assays. Direct observation of intracellular protein to specific PIP[n]s will be possible. These reagents can be employed in development of a multitude of high- throughput screening and genetic based assays.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA085089-01
Application #
6074948
Study Section
Special Emphasis Panel (ZRG1-SSS-Z (01))
Program Officer
Strasburger, Jennifer
Project Start
2000-04-01
Project End
2001-02-28
Budget Start
2000-04-01
Budget End
2001-02-28
Support Year
1
Fiscal Year
2000
Total Cost
$104,515
Indirect Cost
Name
Echelon Biosciences, Inc.
Department
Type
DUNS #
179151188
City
Salt Lake City
State
UT
Country
United States
Zip Code
84108